Group 1 - Cronos Group Inc. held its Annual Meeting of Shareholders on June 20, 2025, with 276,989,452 common shares voted, representing 71.87% of total outstanding shares [1] - All nominated directors were elected, each receiving over 92.3% of the votes in favor of their election, with specific percentages for each director ranging from 92.38% to 96.94% [2] - An advisory resolution on the compensation of named executive officers was approved with 94.13% of votes in favor, and Davidson & Company LLP was appointed as the independent auditor for fiscal year 2025 [2] Group 2 - Cronos is a global cannabinoid company focused on cannabis research, technology, and product development, aiming to build a strong brand portfolio including Spinach®, PEACE NATURALS®, and Lord Jones® [4]
Cronos Group Inc. Announces Results of 2025 Annual Meeting of Shareholders